APOLLOHOSP8,894.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.28L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt3,161.95,275.25,658.55,658.5
Net Debt1,972.43,264.83,830.73,830.7
Total Debt/Equity0.430.610.570.57
Net Debt/Equity0.270.380.380.38
Total Debt/EBITDA1.321.751.501.50
Net Debt/EBITDA0.831.081.020.96
Interest Coverage (EBIT/Interest)3.794.946.446.44
Total Debt/Total Capital %30.1637.8736.2036.20
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.